Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › tulisokibart

tulisokibart

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of tulisokibart

2 trials tracked of tulisokibart.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2
  1. Phase 2 A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005) Completed
  2. Phase 2 A Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006) Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Review of anti-TL1A therapies for hidradenitis suppurativa with no reported outcomes or safety data
Cardiology Sys. Review
Review of anti-TL1A therapies for hidradenitis suppurativa with no reported outcomes or safety data New review looks at anti-TL1A therapies for hidradenitis suppurativa
This narrative review discusses anti-TL1A therapies, specifically tulisokibart, for hidradenitis suppurativa.
A new review explores anti-TL1A therapies for hidradenitis suppurativa, offering fresh insights into treating this painful skin condition.
Frontiers Apr 23, 2026